ASI 2017* , ,
Presentations this author is a contributor to:
Development of an in vivo model to study the effects of monoclonal antibody treatment of squamous cell carcinoma (#247)
4:00 PM
Xuzhi (Jessica) He
Poster Session Two
CESTEM-1 clinical trials: using dynamin inhibitors to reverse resistance to monoclonal antibody therapy. (49404)
3:20 PM
Fiona Simpson
Tumour Immunology Workshop Session V: Translational Immunotherapy